Skip to Content

GG 957 (Methylprednisolone 4 mg)

Pill imprint GG 957 has been identified as Methylprednisolone 4 mg.

Methylprednisolone is used in the treatment of inflammatory conditions; allergic rhinitis; gout, acute; dermatologic lesion; asthma (and more), and belongs to the drug class glucocorticoids. Excluding first trimester: Risk cannot be ruled out during pregnancy. First trimester: There is positive evidence of human fetal risk during pregnancy. Methylprednisolone 4 mg is not a controlled substance under the Controlled Substance Act (CSA).

Methylprednisolone 4 mg GG 957  Front
Methylprednisolone 4 mg GG 957  Back
Methylprednisolone 4 mg GG 957
Methylprednisolone 4 mg GG 957
GG 957
4 mg
8.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Pregnancy Category:
C - Risk cannot be ruled out - excluding first trimester
D - Positive evidence of risk - first trimester
CSA Schedule:
Not a controlled drug
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
lactose monohydrate
magnesium stearate
microcrystalline cellulose
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
66267-0961 Nucare Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.